| |
| |
|
| Insider
Information: |
Gallahue Kieran |
| Relationship: |
Director |
| City: |
Poway Ca |
| State: |
X1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
85,120 |
|
|
Indirect Shares
|
70,920 |
|
|
| Direct
Value |
$12,545,324 |
|
|
|
Indirect Value
|
$2,119,848 |
|
|
| Total
Shares |
156,040 |
|
|
| Total
Value |
$14,665,172 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 4.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ResMed Inc |
RMD |
Chief Executive Office... |
2011-01-05 |
56,921 |
2004-11-11 |
0 |
Premium* |
|
|
Volcano Corp |
VOLC |
Director |
2015-02-17 |
0 |
2011-05-02 |
0 |
Premium* |
|
|
CareFusion Corporation |
CFN |
Chairman and CEO, Dire... |
2015-03-17 |
0 |
2012-01-29 |
0 |
Premium* |
|
|
Edwards Lifesciences Corp |
EW |
Director |
2024-05-08 |
4,054 |
2024-05-08 |
70,920 |
Premium* |
|
|
Intersect Ent, Inc. |
XENT |
|
2022-05-13 |
0 |
2022-05-13 |
0 |
Premium* |
|
|
Arena Pharmaceuticals Inc |
ARNA |
Director |
2022-03-11 |
0 |
2022-03-11 |
0 |
Premium* |
|
|
Envista Holdings Corp |
NVST |
Director |
2023-05-23 |
24,145 |
2019-12-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
156 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARNA |
Arena Pharmaceuticals Inc |
Director |
– • – |
2019-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,654 |
7,398 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
Executive Chairman |
• • – |
2019-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
17,202 |
29,262 |
0 |
- |
|
| NVST |
Envista Holdings Corp |
Director |
– • – |
2019-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,035 |
2,035 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
• • – |
2020-05-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,737 |
0 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
• • – |
2020-05-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,737 |
17,471 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
• • – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,446 |
1,446 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
|
– • – |
2020-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,011 |
34,273 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
Director |
– • – |
2020-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,446 |
9,844 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
• • – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,433 |
3,433 |
0 |
- |
|
| NVST |
Envista Holdings Corp |
Director |
– • – |
2021-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,020 |
14,285 |
0 |
- |
|
| XENT |
Intersect Ent, Inc. |
|
– • – |
2021-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,239 |
8,250 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
Director |
– • – |
2021-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,067 |
9,283 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
Director |
– • – |
2022-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,283) |
0 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
Director |
– • – |
2022-03-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,628) |
0 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
• • – |
2022-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
3,037 |
3,037 |
0 |
- |
|
| NVST |
Envista Holdings Corp |
Director |
– • – |
2022-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,435 |
18,720 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
• • – |
2023-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,701 |
3,701 |
0 |
- |
|
| NVST |
Envista Holdings Corp |
Director |
– • – |
2023-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
5,425 |
24,145 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
• • – |
2024-02-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
7,056 |
70,277 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
• • – |
2024-02-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,056 |
3,701 |
0 |
- |
|
| EW |
Edwards Lifesciences Corp |
Director |
• • – |
2024-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,054 |
4,054 |
0 |
- |
|
| RMD |
ResMed Inc |
Chief Executive Officer |
• • – |
2009-10-26 |
4 |
OE |
$15.99 |
$27,974 |
D/D |
1,750 |
4,974 |
0 |
- |
|
| RMD |
ResMed Inc |
Chief Executive Officer |
• • – |
2009-10-23 |
4 |
OE |
$15.99 |
$51,951 |
D/D |
3,250 |
6,474 |
0 |
- |
|
| RMD |
ResMed Inc |
Chief Executive Officer |
• • – |
2009-05-11 |
4 |
OE |
$15.99 |
$79,925 |
D/D |
5,000 |
8,224 |
0 |
- |
|
| RMD |
ResMed Inc |
Chief Executive Officer |
• • – |
2009-06-12 |
4 |
OE |
$15.99 |
$79,925 |
D/D |
5,000 |
8,224 |
0 |
- |
|
156 Records found
|
|
Page 2 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
